Settlement reached with cystic fibrosis drug manufacturer

FRANKFORT, Ky. (AP) - Kentucky's Medicaid program will receive
more than $135,000 in a settlement with the manufacturer of a
cystic fibrosis drug.
Attorney General Jack Conway announced Wednesday that Kentucky
was part of a $75.2 million settlement with Novartis
Pharmaceuticals Corp.
The settlement with the Switzerland-based company resolves
claims that Novartis had knowingly promoted the sale and use of
tobramycin for uses not approved by the U.S. Food & Drug
Administration.
Kentucky will receive more than $470,000, which is double the
amount the state's Medicaid program spent on prescriptions written
as a result of the company's off-label marketing. After reimbursing
the federal government for its contribution, the Kentucky Medicaid
program will retain $136,199.

(Copyright 2010 by The Associated Press. All Rights Reserved.)


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus

WKYT

2851 Winchester Rd. Lexington, Ky 40509 859-299-0411 - switchboard 859-299-2727 - newsroom
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 92968284 - wkyt.com/a?a=92968284
Gray Television, Inc.